Motor Performance Improvement After Visual Rehabilitation (NCT06698172) | Clinical Trial Compass
RecruitingNot Applicable
Motor Performance Improvement After Visual Rehabilitation
Spain30 participantsStarted 2024-11-29
Plain-language summary
Acquired brain injury" refers to brain damage that impacts neurological processing, making daily activities challenging and often causing vision issues like binocular dysfunction, oculomotor problems, and visual field loss. In Spain, visual rehabilitation is limited, although it is more common in other countries.
These patients generally need an interdisciplinary approach involving professionals like physiotherapists and optometrists and often face mobility, balance, and spatial perception difficulties. Treatment tools include lenses, prisms, and technologies like virtual reality (VR). The Visionary VR program, presented by Dr. Portela, has shown promising results in visual field recovery by stimulating the affected area.
Visual rehabilitation is based on brain plasticity and involves three key strategies:
Prisms to expand the visual field. Compensatory therapy to improve eye movement. Restitution therapy to restore the visual field.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult subjects diagnosed with acquired brain injury either from a stroke or trauma.
* Subjects without cognitive impairment.
* Subjects without pre-existing musculoskeletal disorders prior to the acquired brain injury.
* Subjects without hemineglect.
* Subjects with more than 6 months of progression since the brain injury.
* Subjects who have an electronic device such as a computer and internet access to perform the exercises at home.
* Subjects with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.
Exclusion Criteria:
* Not signing the informed consent.
* Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
* Uncontrolled epilepsy.
* Subjects with glaucoma or retinal pathologies affecting the visual field.
* Subjects with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
* Subjects who are not stable in any associated clinical pathology or otherwise diagnosed.
* Subjects who have previously undergone visual rehabilitation for the field defect.
* Not performing the proposed home exercises.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual field
Timeframe: 15 minutes
2
Balance
Timeframe: 15 minutes
Trial details
NCT IDNCT06698172
SponsorInstituto de Investigación Sanitaria Aragón